SCHOFIELD, Wis., Jan. 20, 2010 (GLOBE NEWSWIRE) -- PuraMed BioScience (OTCBB:PMBS) announced today that CEO Russell Mitchell will be interviewed live by Stockgoodies.com, a G6 Stocks community, at 8:30 a.m. ET on Thursday, January 21, 2010.
The interview can be heard on the Stockgoodies homepage, www.stockgoodies.com.
Mitchell will introduce PuraMed Bioscience and discuss how it has recently begun to generate revenue for the first time as a result of its e-commerce website, www.MyMigraineGone.com, and initial test launch of its direct response commercial featuring LipiGesic™ M, a non-prescription medication for migraine headaches.
About the Company:
PuraMed BioScience, Inc. engages in the research, development and marketing of non-prescription medicinal and healthcare products. In addition to its leading product LipiGesic™ M, which provides acute relief from migraine headaches, the Company also has plans to launch LipiGesic™ PM that provides a remedy for insomnia and other sleep disorders as well as LipiGesic™ H for common tension headaches. For more information on PuraMed, visit the Company website at www.PuraMedBioScience.com, join the Company’s group page on Facebook by searching “PuraMed BioScience” and follow the Company on Twitter at www.twitter.com/puramed.
Forward Looking Statements:
This news release contains forward-looking statements regarding PuraMed BioScience and its future business plans, which statements involve known and unknown risks and uncertainties. Such risks and uncertainties may cause actual results and future achievements of PuraMed BioScience to be materially different than those implied by these forward-looking statements. PuraMed BioScience has and undertakes no obligation to provide public updates and revisions to these forward-looking statements to reflect any changes in its expectations of future events.